Aller au contenu

Michaël Marchand-Gareau

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département de chirurgie - Service d'ophtalmologie

Présentation

Sujets, disciplines ou intérêts de recherche

Ophthalmology, Cornea, Glaucoma, Glaucoma surgery, Artificial intelligence, Normal tension glaucoma, Minimally invasive glaucoma surgery (MIGS)

Adhésions

  • (2022-). Canadian Glaucoma Society (CGS). Ottawa, ON, Canada.
  • (2021-). American Glaucoma Society. San Francisco, CA, États-Unis.
  • (2021-). Royal College of Physicians and Surgeons of Canada. Ottawa, ON, Canada.
  • (2020-). American Academy of Ophthalmology. San Francisco, États-Unis.
  • (2020-). Canadian Ophthalmological Society (COS). Ottawa, ON, Canada.

Diplômes

  • (2020-2021). Glaucoma Fellow. Ophthalmology. University of California Davis Health System Eye Center. Sacramento, CA, États-Unis.
  • (2015-2020). Ophthalmology Residency (FRCSC). Ophthalmology. Université de Montréal Faculté de Médecine. Montreal, QC, Canada.
  • (2015-2020). Researcher. Ophthalmology. Centre Hospitalier de l'Université de Montréal Centre de Recherche. Montreal, QC, Canada.
  • (2010-2015). M.D. Medicine. Université de Montréal. Montreal, QC, Canada.

Expériences académiques

  • Assistant Professor, Residency Program Director. (2021-). Universite de Sherbrooke Faculté de Médecine et des Sciences de la Santé. Sherbrooke, QC, Canada.
  • Glaucoma Fellow. (2020-2021). University of California Davis Health System Eye Center. Sacramento, CA, États-Unis.
  • Resident physician. (2015-2020). Centre Hospitalier de l’Université de Montréal. Montreal, QC, Canada.

Prix et distinctions

  • (2025) André-Plante Award Finalist. Université de Sherbrooke.
  • (2019) Roch Gagnon Award. Université de Montréal.
  • (2013) First Prize in Fundamental Research. Quebec Society of Vascular Science (QSVS).
  • (2010) Governor General's Academic Medal (college level). Her Majesty's Government.
  • (2008) Governor General's Academic Medal (high school level). Her Majesty's Government.

Financement

  • Subvention. Autologous 20% Serum Drops in the Resolution of Corneal Epitheliopathy Associated with Antihypertensive Drops for Glaucoma: A Randomized Controlled Trial. University of Sherbrooke (Sherbrooke, Canada). 10 000 $. (2023).

Publications

Articles

  • Kevin Y. Wu, Shu Yu Qian, Lysa Houadj, Michael Marchand. (2025). Efficacy and Safety of Kahook Dual Blade Goniotomy and Trabecular Micro-Bypass Stent in Combination with Cataract Extraction. Biomimetics. DOI
  • Xingao C. Wang, Cindy Zhao, Kevin Y. Wu, Michael Marchand. (2025). Ophthalmic Complications After Dental Procedures: Scoping Review. Diseases. DOI
  • Kevin Y. Wu, Shu Yu Qian, Michael Marchand. (2025). Evaluating ChatGPT-4 Plus in Ophthalmology: Effect of Image Recognition and Domain-Specific Pretraining on Diagnostic Performance. Diagnostics. DOI
  • Kevin Y. Wu, Rebecca Khammar, Hafsah Sheikh, Michael Marchand. (2024). Innovative Polymeric Biomaterials for Intraocular Lenses in Cataract Surgery. Journal of Functional Biomaterials. DOI
  • Kevin Y. Wu, Sameer Khan, Zhuoying Liao, Michael Marchand, Simon D. Tran. (2024). Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems. Polymers. DOI
  • Kevin Y. Wu, Mina Mina, Marjorie Carbonneau, Michael Marchand, Simon D. Tran. (2023). Advancements in Wearable and Implantable Intraocular Pressure Biosensors for Ophthalmology: A Comprehensive Review. Micromachines. DOI
  • Kevin Y. Wu, Said Ashkar, Shrieda Jain, Michael Marchand, Simon D. Tran. (2023). Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma. Polymers. DOI
  • Michael Marchand, Jonathan El-Khoury, Mona Harissi-Dagher, Marie-Claude Robert. (2022). Outcomes of first cases of DMEK at a Canadian university hospital centre. Canadian Journal of Ophthalmology. DOI
  • Dominique Geoffrion, Salima I. Hassanaly, Michael Marchand, Roy Daoud, Younes Agoumi, Mona Harissi-Dagher. (2022). Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. American Journal of Ophthalmology. DOI
  • Michael Marchand, Harmanjit Singh, Younes Agoumi. (2021). Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Canadian Journal of Ophthalmology. DOI
  • Jessica El-Khazen Dupuis, Michael Marchand, Simon Javidi, Tuan Quynh Tram Nguyen. (2021). Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma. International Medical Case Reports Journal. DOI
  • Jonathan El-Khoury, Michael Marchand, Guy Allaire, Marie-Claude Robert. (2020). Conjunctival stromal tumour: case report and review of the literature. Canadian Journal of Ophthalmology. DOI
  • Michael Marchand, Mona Harissi-Dagher. (2020). Recurrent preseptal cellulitis in Boston keratoprosthesis type II implantation for ocular Stevens-Johnson syndrome. Canadian Journal of Ophthalmology. DOI
  • Michael Marchand, Mona Harissi-Dagher, Marc Germain, Paul Thompson, Marie-Claude Robert. (2018). Serum drops for ocular surface disease: national survey of Canadian cornea specialists. Canadian Journal of Ophthalmology. DOI

Chapitres de livre

  • Kevin Y. Wu, Rahma M. Osman, Obinna Esomchukwu, Michael Marchand, Bich H. Nguyen, Simon D. Tran. (2025). Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Glaucoma and Retinal Diseases. Advances in Experimental Medicine and Biology. DOI
  • Kevin Y. Wu, Meihua E. Su, Yeonsu Kim, Louis Nguyen, Michael Marchand, Simon D. Tran. (2025). Wearable biosensors: A comprehensive overview. Progress in Molecular Biology and Translational Science. DOI

Autres contributions

Activités professionnelles

  • Université de Sherbrooke. Faculty of Medicine and Health Sciences. Ophthalmology Residency Program Director. Sherbrooke, Quebec, Canada. (2023-).
  • Journal of Glaucoma. Reviewer. (2020-).

Divers

  • Kevin Y. Wu, Maxine Joly‐Chevrier, Laura K. Gorwill, Michael Marchand, Simon D. Tran. (2024). Advancements in Bioprinting for Medical Applications. 3D Bioprinting from Lab to Industry.